Simplify Asset Management’s Zevra Therapeutics ZVRA Stock Holding History

Simplify Asset Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Sell	70,759 -29,871	-30%	-$332K	0.01%	81
2026 Q1	$938K	Buy	100,630 +58,265	+138%	+$525K	0.01%	77
2025 Q4	$380K	Sell	42,365 -104,635	-71%	-$990K	0.01%	110
2025 Q3	$1.4M	Hold	147,000	–	–	0.03%	71
2025 Q2	$1.3M	Buy	147,000 +27,000	+23%	+$219K	0.07%	57
2025 Q1	$899K	Hold	120,000	–	–	0.03%	66
2024 Q4	$1M	Hold	120,000	–	–	0.05%	63
2024 Q3	$833K	Buy	+120,000	New	+$815K	0.04%	78

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Simplify Asset Management's ZVRA Position: Q2 2026 in Review

Simplify Asset Management reduced its Zevra Therapeutics (ZVRA) stake by 30% in Q2 2026, selling an estimated $332K and leaving 70,759 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #81.

Simplify Asset Management first reported a position in ZVRA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.4M in Q3 2025. 54 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Simplify Asset Management held 70,759 shares of Zevra Therapeutics worth $1.01M as of Q2 2026.
Simplify Asset Management sold 29,871 Zevra Therapeutics shares in Q2 2026, an estimated $332K.
Zevra Therapeutics made up 0.01% of Simplify Asset Management's portfolio in Q2 2026, its #81 holding.
Simplify Asset Management first reported a position in Zevra Therapeutics in Q3 2024 and has held it in 8 quarters since.
Simplify Asset Management's Zevra Therapeutics position peaked at $1.4M in Q3 2025.
54 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.